Fresenius Medical Care AG (NYSE:FMS)
$ 23.91 -0.030 (-0.13%) Market Cap: 12.84 Bil Enterprise Value: 24.69 Bil PE Ratio: 12.51 PB Ratio: 0.86 GF Score: 74/100

Q1 2026 Fresenius Medical Care AG Earnings Call Transcript

May 05, 2026 / 12:00PM GMT
Release Date Price: $20.19 (-10.86%)
Dominik Heger
Fresenius Medical Care AG - Head of Investor Relations, Strategic Development & Communications, EVP

Thank you, Valentina. I would like to welcome everyone to our earnings call for the first quarter of 2026. As always, I'll start out the call by mentioning our cautionary language that is in our safe harbor statement as well as in our presentation. And in all the materials that we have distributed earlier today. For further details concerning risks and uncertainties, please refer to these documents and to our SEC filings.

We will have a little bit under an hour for the call. In order to give everyone the chance to ask questions, we would limit the number of questions to two. Thank you for making this work as always. Let me now welcome Helen Giza, CEO and Chair of the Management Board; and Martin Fischer, our Chief Financial Officer. Helen, the floor is yours.

Helen Giza
Fresenius Medical Care AG - Chairman of the Management Board, Chief Executive Officer

Thank you, Dominik. I'd like to extend a warm welcome to everyone on the call.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot